Veterinary Bone Grafts and Substitutes Market - By Product Type, By Animal, By Form, By Application, By End Use - Global Forecast, 2025 - 2034

Veterinary Bone Grafts and Substitutes Market Size

The global veterinary bone grafts and substitutes market was valued at USD 245.1 million in 2024. The market is expected to grow from USD 256.9 million in 2025 to USD 448.6 million in 2034, growing at a CAGR of 6.4% during the forecast period. The growing prevalence of orthopedic ailments and fractures among pets and farm animals is a key factor contributing to market growth.
 

Orthopedic conditions such as osteoarthritis, bone injuries, age-associated ailments, and trauma are considered the most important factors escalating the requirement for veterinary bone grafts and substitutes. For example, in veterinary medicine, osteoarthritis stands out as the most prevalent joint ailment. Although age is a risk factor, osteoarthritis can affect pets even at a younger age. In the U.S, approximately 14 million adult dogs suffer from osteoarthritis, which has become a significant concern for pet owners. Owing to the high prevalence of such orthopedic conditions, there is growing adoption of bone grafts and substitutes as pet owners and livestock farmers seek better treatment options to improve the mobility and quality of life of animals.
 

In addition, the increasing veterinary adoption of regenerative medicine and biotechnology is benefitting market growth. The introduction of allografts, xenografts, and several other synthetic bone graft substitutes has broadened the scope of treatment options available to veterinary practitioners. There is increasing demand for bone grafting biocompatible materials like hydroxyapatite and calcium phosphate ceramics due to their ability to aid in bone regeneration while minimizing complications. Moreover, the development of next-generation bone graft substitutes is being bolstered by research in stem cell therapy and tissue engineering, resulting in enhanced treatment outcomes and faster healing times in animals.
 

The expanding pet healthcare expenditure and rising awareness of sophisticated veterinary services are additional factors propelling growth in the market. Pet parents, especially in developed regions like North America and Europe with expanding pet insurance coverage, are more likely to pay for specialized orthopedic care. Furthermore, a growing number of veterinary hospitals and specialized clinics are now offering orthopedic and trauma care, thus increasing the osteogenic and osteoinductive demand for bone grafts and substitutes. Emerging markets in the Asia Pacific and Latin America are also gaining traction due to enhanced veterinary infrastructure combined with improving disposable income, thus providing new avenues for market players.
 

Veterinary bone grafts and substitutes are materials, either biological or synthetic, that are used to repair and regenerate lost or damaged bone tissue in animals. These bone grafts are used in orthopedic surgeries for fracture repair, bone defects, and other diseases of the bones and joints in pets and livestock animals. These grafts accelerate bone healing by offering adequate support frameworks for the bone structure and facilitating osteogenesis, thus improving recovery outcomes in veterinary patients.
 

Veterinary Bone Grafts and Substitutes Market Trends

• Increasing global population of pets, rising trend of pet humanization, and increased consumer spending on pet health, positively influences the market growth. As per data published by Health for Animals, there are likely over a billion pets worldwide. Families in the U.S., Brazil, EU, and China alone account for over half a billion dogs and cats, while more than half the world is estimated to have a pet at home.
   
• As owners increasingly consider pets as a part of their family, the average amount spent per household on pets is rising. For example, an average American pet owner spent USD 1,960 on their pet(s) in 2023. The average pet dog costs USD 143 per month in 2024; cat ownership costs USD 90.50 per month, per cat. Thus, as households increase their spending on pets, there is a higher spending on animal healthcare products and services, thereby fueling market growth.
   
• Also, the wide range of orthopedic conditions in aging pets and large breed dogs is an important contributor to the veterinary bone graft market. Osteoarthritis, hip dysplasia, alongside traumatic fractures, are more prevalent now due to the longer lifespan of pets along with lifestyle factors like obesity.
   
• Several working and performance horses often sustain severe musculoskeletal injuries, which require surgical treatment. For instance, the prevalence of OA is more than 50% in horses older than 15 years, and in horses over 30 years, it increases to 80–90%. Therefore, bone grafts and substitutes are used to improve the healing processes of bones and enhance mobility, thus contributing to an increasing market.
   
• Further, the high adoption of pet insurance is expected to be an instrumental factor in driving the market expansion. In the State of the Industry 2024 Report, NAPHIA highlighted that more than 6.25 million pets were insured across the region last year. The U.S accounted for 90% of the pets insured.  Thus, surging adoption of pet insurance coupled with the growing number of insured animals will drive the market expansion.
   

Veterinary Bone Grafts and Substitutes Market Analysis

Based on the product type, the market is segmented into autografts, allografts, xenografts, and other product types. In 2024, autografts segment accounted for highest market share with a revenue of USD 99.8 million.
 

• Due to its effectiveness in bone regeneration, the autografts segment commands a substantial share in the veterinary bone grafts and substitutes market. Autografts, which involve harvesting bone tissue from the same animal, is regarded as the gold standard in orthopedic and dental procedures performed on pets and livestock. Such grafts possess osteogenic, osteoinductive, and osteoconductive capabilities that ensure better integration to the recipient's bone.
   
• Veterinary surgeons prefer autografts because they eliminate the risk of immune rejection and disease transmission, as they are often concerns with allografts and synthetic substitutes.
   
• Additionally, advancements in minimally invasive surgical techniques have made autograft harvesting easier and more efficient, thereby driving the adoption of this segment.

Based on the animal, the veterinary bone grafts and substitutes market is classified into dogs, cats, horses, and other animals. The dogs segment held the highest revenue in 2024 with a market share of 56.6%.
 

• The increasing segmental growth is attributed to the rising adoption rate of dogs as companion animals coupled with growing expenditure on dogs. For instance, in 2021, according to the American Pet Products Association (APPA), 90.5 million families own a pet in the U.S. among which 69 million (over 76%) households own a dog.
   
• Also, countries in Europe such as U.K, Poland, and France are noted to have some of the highest population of pet dogs. Thus, high population of dogs as compared to other companion animals is expected to create a considerable growth opportunity for bone grafts and substitutes for dogs.
   
• Further, high incidence of orthopedic and dental diseases in dogs coupled with increasing cases of trauma and injury, further boosts the segmental growth. For instance, periodontal disease is one of the most common diseases affecting dogs, with a reported prevalence of at least 80% in dogs over 3 years of age. This rising burden of dental diseases in dogs translates to greater demand for veterinary bone grafts and substitutes.
   

Based on the form, the veterinary bone grafts and substitutes market is classified into powders, putty, granules, injectables, and other forms. The injectables segment dominated the market in 2024 and is anticipated to witness rapid growth at a CAGR of 6% over the forecast years.
 

• The injectables segment has a high market share in the veterinary bone grafts and substitutes market due to ease of application, reduced surgical time, and improved healing properties.
   
• Injectable bone grafts are often made of synthetic materials such as demineralized bone matrix (DBM), or other bioactive constituents, offer veterinarians a minimally invasive solution for bone regeneration.
   
• Unlike conventional methods of grafting, injectables enhance the uniform graft material distribution, allowing for better bone integration and healing. 
   
• Moreover, the growing adoption of minimally invasive techniques in orthopedic and dental veterinary medicine increases the demand for injectable bone grafts.
   
• The increasing use of graft substitutes, both synthetic and allogeneic, instead of autografts is another key factor propelling the dominance of the injectables segment.
   

Based on the application, the market is classified into orthopedic, dental, and other applications. The orthopedic segment dominated the market in 2024 and is anticipated to witness rapid growth at a CAGR of 6.3% over the forecast years to reach USD 243.3 million by 2034.
 

• The orthopedic segment commands a significant share of the veterinary bone grafts and substitutes market because of the increasing cases of fractures, bone defects, and degenerative bone disorders among companion and livestock animals.
   
• Increased adoption of veterinary orthopedic surgeries to treat conditions such as osteoarthritis, bone tumors, and trauma injuries have increased the need for bone grafts. These materials provide structural support and facilitate bone healing, making them essential for repairing traumatic injuries, degenerative conditions, and congenital deformities.
   
• Furthermore, increasing awareness among pet owners regarding advanced surgical treatments and the growing tendency of specialty veterinary practices and clinics to incorporate advance bone grafting techniques into their procedures has also intensified the acceptance of bone graft substitutes.
   

Based on the end use, the market is bifurcated into veterinary hospital, veterinary clinics, and other end users. In 2024, the veterinary hospital segment dominated the veterinary bone grafts and substitutes market with a revenue of 138.1 million and is expected to grow at CAGR of 6.2% from 2025 to 2034.
 

• Veterinary hospitals command a dominant share in the market because of the increasing orthopedic surgeries performed in these facilities. The high volume of surgeries performed in these settings, combined with their access to the latest technologies and expertise, drives demand for bone grafts and substitutes.
   
• Veterinary hospitals have advanced surgical facilities which along with skilled veterinary doctors enable them to manage intricate orthopedic and dental surgeries in animals.
   
• These facilities often handle complex cases requiring advanced bone grafting techniques, making them key users of these technologies.

North America market held the largest market share of 44.3% in 2024 in the global veterinary bone grafts and substitutes market, and it is anticipated to expand at a 6% CAGR over the forecast period.
 

The U.S. veterinary bone grafts and substitutes industry was valued at USD 88.3 million in 2021. The market size was valued at USD 91.4 million in 2022 and reached USD 94.8 million in 2023.
 

• High rates of pet ownership in the country coupled with early adoption of advanced technology drives the market growth. According to the 2021–2022 National Pet Owners Survey by the American Pet Products Association (APPA), 70% of the U.S. households owned at least one type of pet. Similarly, almost 45.3 million of the U.S. households have at least one cats, and 3.5 million have horse, and 69 million have at least one dog.
   
• Also, the country possesses a robust chain of veterinary hospitals and specialty clinics that routinely conduct orthopedic and dental surgeries with bone grafting, further driving the demand. For instance, in April 2024, UC Davis Veterinary Medical Teaching Hospital launched the Advanced Veterinary Surgery Center, a cutting-edge facility dedicated to orthopedic procedures.
   
• The U.S. market is further strengthened by the presence of major companies and distributors of veterinary bone grafts and substitutes, which ensure a constant supply of advanced and effective veterinary bone grafts and substitutes, thereby aiding in the overall market growth.
   

Europe market accounted for USD 63.9 million in 2024 and is anticipated to show considerable growth over the forecast period.
 

• Europe accounts for a significant share of the global veterinary bone grafts and substitutes market owing to the advanced veterinary healthcare system and infrastructure in the region, high pet ownership, and increasing adoption of modern orthopedic procedures for animals.
   
• Also, the presence of well-established veterinary hospitals and specialty clinics that employ advanced surgical techniques including bone grafting, further boosts the Europe market.
   
• The robust safety and effectiveness of regulatory policies pertaining to veterinary medical products also contribute to Europe’s leading position in the market.
   
• Further, Germany is home to several key manufacturers and suppliers of veterinary biomaterials who ensure the supply of innovative bone grafts, autografts, allografts, and various synthetic substitutes.
   

India veterinary bone grafts and substitutes market is poised to witness high growth over the analysis period.
 

• India's veterinary market for bone grafts and substitutes is evolving rapidly. This is primarily due to the rising cases of bone-related issues and fractures among pets and livestock animals.
   
• Also, with more people adopting pets particularly in urban areas, there is a higher need for specialized veterinary care, including orthopedic procedures that involve bone grafting.
   
• The expanding veterinary healthcare infrastructure in the country is aiding the market growth. The country is seeing an increase in the number of specialized veterinary hospitals, clinics, and research institutions investing in advanced orthopedic procedures. 
   
• Furthermore, government-driven animal healthcare programs, along with the collaborations of veterinary research institutes with biotechnology companies, are additionally aiding market growth.
   

Brazil veterinary bone grafts and substitutes market is anticipated to witness rapid growth over the forecast years.
 

• The Brazil industry is expanding due to increased awareness and demand for advanced veterinary orthopedic treatments, particularly for managing conditions like osteoarthritis and fractures in pets. Rising pet ownership and higher expenditure on pet health are fueling the demand for specialized veterinary treatments, including bone grafts and substitutes.
   
• For instance, Brazil has the third-largest pet population in the world with 160 million pets, of which 60 million are dogs, 30 million cats, and 32 million pet-owning households. The country is also home to a large livestock population, with Brazil being the third-largest cattle producer and second-largest beef exporter in the world. Such high animal volume coupled with strong growth in veterinary expenditure is anticipated to foster the market growth.
   
• Additionally, the presence of several international as well as local veterinary companies in the country further aid in the market growth.
   

Veterinary Bone Grafts and Substitutes Market Share

Veterinary bone grafts and substitutes industry competition include larger medical device firms, niche veterinary biomaterial companies, and emerging startups developing innovative grafting solutions. Top 3 players including Movora (Vimian Group AB), TheraVet SA, and Biomendex hold a strong position in the market with a combined share of approximately 20 - 25%. Market participants concentrate on differentiating their products with advanced biomaterials like demineralized bone matrices (DBMs), synthetic bone grafts, and collagen-based scaffolds that improve the healing and regeneration of bones. There is an increase in spending on research and development related to biocompatibility, integration, and osteoinductive capabilities of the grafts. Finally, strategic partnerships with veterinary clinics, hospitals, and academic institutions are aiding in increasing the market presence of the companies and gaining competitive advantages.
 

Veterinary Bone Grafts and Substitutes Market Companies

Prominent players operating in the veterinary bone grafts and substitutes industry include:

• Biomendex
• BioChange
• Biomimetic Solutions
• Cavix
• Exabone
• Lynch Biologics
• Movora (Vimian Group AB)
• Nutramax Laboratories Veterinary Sciences
• Rita Leibinger
• S-VETOSS
• TheraVet
• Veteregen
• Wishbone
   

Movora, a subsidiary of Vimian Group AB, is a key player in the veterinary bone grafts and substitutes market, offering a range of orthopedic solutions for companion animals. The company provides allograft, xenograft, and synthetic bone substitute products to support veterinary surgical procedures, enhancing bone healing and regeneration.
 

TheraVet is a veterinary biotechnology company specializing in bone graft substitutes and regenerative therapies for companion animals. Its key product, Biocera-Vet, offers innovative bone surgery solutions, including injectable and moldable bone substitutes, to enhance bone healing and repair in veterinary orthopedics.
 

Veterinary Bone Grafts and Substitutes Industry News

• In February 2022, TheraVet announced an exclusive partnership aimed at expanding its bone substitutes portfolio. This partnership introduces a new biological bone graft product line, BIOCERA-VET SmartGraft, which complements TheraVet's existing synthetic bone graft offerings. The introduction of BIOCERA-VET SmartGraft further strengthens the company’s position as a provider of one of the most comprehensive portfolios of bone substitutes in the veterinary market.
   
• In January 2024, Biomendex and Jorgensen Laboratories (Jorvet) entered a collaboration agreement to distribute AdaptosVet across the U.S., Canada, and Mexico.
   
• In January 2024, TheraVet signed a partnership agreement with Alcyon Italia to distribute its BIOCERA-VET line of bone substitutes in Italy, using Alcyon’s extensive network and expertise in orthopedic distribution. This collaboration includes the promotion of 13 BIOCERA-VET products, supported by clinical trials and educational initiatives aimed at Italian veterinarians. 
   

The veterinary bone grafts and substitutes market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Autografts
• Allografts
• Xenografts
• Other product types

Market, By Animal

• Dogs
• Cats
• Horses
• Other animals

Market, By Form

• Powders
• Putty
• Granules
• Injectables
• Other forms

Market, By Application

• Orthopedic
• Dental
• Other applications

Market, By End Use

• Veterinary hospitals
• Veterinary clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudia Arabia
  • UAE